Influenza A Influenza is a highly contagious respiratory infection, which affects approximately 9% of the global population and causes 300,000 to 500,000 deaths annually. Based on their core proteins, influenza viruses are classified into types A, B, C, and D. While both influenza A and B can cause epidemics in humans, influenza A also has pandemic potential and a higher mutation rate and is therefore most significant to public health. Influenza A viruses are further classified into subtypes, based on the combinations of the surface
glycoproteins
hemagglutinin (HA) and
neuraminidase (NA). The primary natural reservoir for most influenza A subtypes are wild aquatic birds; A key determinant of whether a particular influenza A subtype can infect humans is its binding specificity. Avian influenza A preferentially binds to cell surface receptors with a terminal α2,3‐linked
sialic acid, while human influenza A preferentially binds to cell surface receptors with a terminal α2,6‐linked sialic acid. Via mutation, some avian influenza A viruses have successfully altered their binding specificity from α2,3‐ to α2,6‐linked sialic acid. However, in order to emerge in humans, avian influenza A viruses must also adapt their
RNA polymerases for function in mammalian cells, as well as mutating for stability in the acidic respiratory tract of humans. Following
adaptation and
host switch, influenza A viruses have the potential to cause epidemics and pandemics in humans. Minor changes in HA and NA structure (
antigenic drift) occur frequently, which enables the virus to cause repetitive outbreaks (i.e.,
seasonal influenza) by evading immune recognition. Additionally, although animal influenza A viruses (e.g.,
swine influenza) are distinct from human influenza viruses, they can still cause zoonotic infection in humans. These infections are largely acquired following direct contact with infected animals or contaminated environments, but do not result in efficient human-to-human transmission; examples of this include
H5N1 influenza and
H7N9 influenza. As SARS-CoV-1 is most contagious post-symptoms, the introduction of strict public health measures effectively halted the epidemic. However, more recent analysis suggests that SARS-CoV-1 may have directly jumped from bats to humans, with subsequent cross-transmission between humans and civets. It is a cytopathic virus. After inhalation of the virus, it causes infection of the airway and organs and subsequent death of cells and tissue. While an intermediate host is still being identified for the COVID-19 pandemic, it is widely believed that this strain of coronavirus matches BANAL-52 bat strains. Because of the similarity to SARS-CoV-1 in how the virus binds to a receptor, it is thought that infected animals, possibly bats, may have spread the virus to humans. The World Health Organization did not find evidence of widespread SARS-CoV-2 infection before 2019.
Vaccines for COVID-19 are being updated to combat new variants that have emerged since the height of the pandemic.
MERS-CoV First reported in 2012,
MERS-CoV (Middle East respiratory syndrome coronavirus) marks the second known introduction of a highly pathogenic coronavirus from a zoonotic reservoir into humans. The case mortality rate of this emergent virus is approximately 35%, with 80% of all cases reported by Saudi Arabia. Although MERS-CoV is likely to have originated in bats,
dromedary camels have been implicated as probable intermediate hosts. MERS-CoV is believed to have been circulating in these mammals for over 20 years, Studies have shown that humans can be infected with MERS-CoV via direct or indirect contact within infected dromedary camels, while human-to-human transmission is limited. Climate change has been implicated in the emergence and global spread of this disease, due to its impact on vector distribution. The natural vector of the bluetongue virus is the African midge
C. imicola, which is normally limited to Africa and subtropical Asia. However, global warming has extended the geographic range of
C. imicola, so that it now overlaps with a different vector (
C. pulcaris or
C. obsoletus) with a much more northward geographic range. This change enabled the bluetongue virus to jump vector, thus causing the northward spread of bluetongue disease into Europe. == See also ==